(Q48846277)

16 February 2018

title

Treatment of Medical Complications in Patients with Brain Tumors. (English)

1 reference

16 February 2018

author name string

Amy A Pruitt

series ordinal

1

1 reference

16 February 2018

publication date

1 July 2005

1 reference

16 February 2018

Current treatment options in neurology

published in

1 reference

16 February 2018

volume

7

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

323-336

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s11940-005-0042-y

exact match

0 references

cites work

Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

Steroid myopathy in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

A diagnostic strategy involving a quantitative latex D-dimer assay reliably excludes deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

Complications of therapy for venous thromboembolic disease in patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

Stroke in patients with cancer: incidence and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

Advising patients who seek complementary and alternative medical therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-005-0042-Y

Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy

21 January 2018

1 reference

12 December 2020

Pneumocystis pneumonia

1 reference

12 December 2020

Corticosteroid insufficiency in acutely ill patients

1 reference

12 December 2020

The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects

1 reference

12 December 2020

Emerging molecular mechanisms of brain tumour oedema.

1 reference

12 December 2020

Herb-drug interactions

1 reference

12 December 2020

Interactions between antiepileptic and chemotherapeutic drugs

1 reference

12 December 2020

Epilepsy in patients with brain tumors and other cancers.

1 reference

12 December 2020

Physicians should administer low-dose corticosteroids selectively to septic patients until an ongoing trial is completed

1 reference

12 December 2020

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions

1 reference

12 December 2020

Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy

1 reference

12 December 2020

Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis

1 reference

12 December 2020

The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review

1 reference

12 December 2020

Venous thrombosis from air travel: the LONFLIT3 study--prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial

1 reference

12 December 2020

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study.

1 reference

12 December 2020

Clinical practice. Care of patients receiving long-term anticoagulant therapy.

1 reference

12 December 2020

Phenytoin-induced severe cutaneous drug reactions: suspected interactions with corticosteroids and H2-blockers

1 reference

12 December 2020

Corticosteroid supplementation for adrenal insufficiency

1 reference

12 December 2020

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

12 December 2020

ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas

1 reference

12 December 2020

Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study

1 reference

12 December 2020

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

12 December 2020

Thromboembolism in brain tumors

1 reference

12 December 2020

Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis

1 reference

12 December 2020

The management of thromboembolic disease in patients with central nervous system malignancies

1 reference

12 December 2020

The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society

1 reference

12 December 2020

The management of brain edema in brain tumors

1 reference

12 December 2020

Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis

1 reference

12 December 2020

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

12 December 2020

Prevention of thromboembolism after neurosurgery for brain and spinal tumors

1 reference

12 December 2020

Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis

1 reference

12 December 2020

Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.

1 reference

12 December 2020

High incidence of thromboembolism in patients with central nervous system lymphoma

1 reference

12 December 2020

Prophylactic anticonvulsants in patients with brain tumour.

1 reference

12 December 2020

New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

1 reference

12 December 2020

Acetazolamide therapy for symptomatic plateau waves in patients with brain tumors. Report of three cases

1 reference

12 December 2020

Medical management of patients with brain tumors

1 reference

12 December 2020

10.1007/S11940-005-0042-Y

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018